www.centogene.com
Open in
urlscan Pro
52.57.235.161
Public Scan
Submitted URL: http://centogene.com/
Effective URL: https://www.centogene.com/
Submission: On September 04 via manual from IN — Scanned from US
Effective URL: https://www.centogene.com/
Submission: On September 04 via manual from IN — Scanned from US
Form analysis 2 forms found in the DOM
GET /search
<form class="t3m-SearchForm relative" action="/search" method="get" data-suggest="/search-api">
<div class="autoComplete_wrapper" role="combobox" aria-owns="autoComplete_list_1" aria-haspopup="true" aria-expanded="false"><input
class="t3m-SearchForm-textInput placeholder-t3m-muted border-t3m-border-color focus:ring-t3m-input-focus-ring-color focus:border-t3m-input-focus-ring-color tx-solr-suggest w-full pr-10 font-light rounded-md" type="text" name="tx_solr[q]"
value="" placeholder="Enter your search term" autocomplete="off" aria-controls="autoComplete_list_1" aria-autocomplete="both">
<ul id="autoComplete_list_1" role="listbox" hidden=""></ul>
</div>
<div class="absolute inset-y-0 right-0 z-10 flex items-center pr-5"><span class="input-group-btn flex"><button class="btn btn-default tx-solr-submit" type="submit"><span><svg class="text-t3m-gray w-4" xmlns="http://www.w3.org/2000/svg"
viewBox="0 0 512 512" fill="currentColor">
<path
d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
</path>
</svg></span></button></span></div>
<div class="t3m-SearchForm-backdrop"></div>
</form>GET /search
<form class="t3m-SearchForm relative" action="/search" method="get" data-suggest="/search-api">
<div class="t3m-SearchForm-textInput-wrapper focus-within:border-transparent border-b border-white">
<div class="autoComplete_wrapper" role="combobox" aria-owns="autoComplete_list_2" aria-haspopup="true" aria-expanded="false"><input
class="t3m-SearchForm-textInput focus:placeholder-t3m-muted focus:bg-white focus:border-transparent focus:ring-t3m-border-color focus:pl-4 focus:pr-10 tx-solr-suggest px-0 py-1 pr-10 font-light text-white placeholder-white transition-all duration-200 bg-transparent border border-transparent rounded-md"
id="" type="text" name="tx_solr[q]" value="" placeholder="Enter your search term" autocomplete="off" aria-controls="autoComplete_list_2" aria-autocomplete="both">
<ul id="autoComplete_list_2" role="listbox" hidden=""></ul>
</div>
<div class="absolute inset-y-0 right-0 flex items-center pr-3"><span class="input-group-btn flex"><button class="btn btn-default tx-solr-submit" type="submit"><span><svg class="w-4 text-white" xmlns="http://www.w3.org/2000/svg"
viewBox="0 0 512 512" fill="currentColor">
<path
d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
</path>
</svg></span></button></span></div>
</div>
<div class="t3m-SearchForm-backdrop"></div>
</form>Text Content
COOKIES SETTINGS This website uses different types of cookies to improve your user experience. You can change your decision at any time via the Cookie Settings. Further information can be found in our Data Protection Policy. You can decide which cookies you allow or reject. You can select from the following three types: Required Required cookies are used to enable basic website functionalities such as page navigation, to verify if a visitor has read the cookie notification, and to save visitor’s cookie settings. Therefore, we use our own cookies. Required cookies cannot be disabled, otherwise our website would not function correctly. Statistical Statistical cookies are used to analyse and improve our website on the basis of general usage patterns. We have external partners who use analysis methods (e.g. cookies or fingerprints) to measure how often our site is visited and how it is used. Marketing We use tracking technologies for marketing purposes, including third parties who may use cookies, fingerprints, tracking pixels and IP addresses across devices. In this context, we also use service providers in third countries outside the EU without an adequate level of data protection, which entails the following risks: Access by authorities without information, no rights of data subjects, no legal remedies, loss of control. With your choice of settings you consent to the processes described above. You can revoke your consent with effect for the future at any time. Third-party multi- and social media content In some cases we embed content from other websites. This embedded content may be photos or videos, but also services such as advanced comment systems and sharing content on social networks. Embedded content can place cookies from these third party websites, which we cannot influence. We offer content from the following providers: Podigee Youtube Privacy policy Accept selected Select all HomeOrder a TestInvestors Centogene Logo Centogene Logo Open menu About Us Why Choose CENTOGENEThe CENTOGENE BiodatabankLeadership TeamAccreditationsInvestors Diagnostics Benefits of Diagnostic TestingOur TestsHow to OrderMultiomic SolutionsNGS PanelsWESWGSCentoCloud® Pharma What We Do for PharmaClinical Trial SupportPatient Identification and StratificationDrug Discovery and DevelopmentBiodata NetworkCENTOGENE Registries Patient What We Do For PatientsGenetic TestingPatient Advocacy Resources WebinarsPodcastScientific PublicationsDownloads About Us Why Choose CENTOGENEThe CENTOGENE BiodatabankLeadership TeamAccreditationsInvestors Diagnostics Benefits of Diagnostic TestingOur TestsHow to OrderMultiomic SolutionsNGS PanelsWESWGSCentoCloud® Pharma What We Do for PharmaClinical Trial SupportPatient Identification and StratificationDrug Discovery and DevelopmentBiodata NetworkCENTOGENE Registries Patient What We Do For PatientsGenetic TestingPatient Advocacy Resources WebinarsPodcastScientific PublicationsDownloads HomeOrder a TestInvestors THE ESSENTIAL BIODATA LIFE SCIENCE PARTNER IN RARE AND NEURODEGENERATIVE DISEASES CENTOGENE’s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. >850,000 INDIVIDUALS IN THE CENTOGENE BIODATABANK >400,000 COLLECTED BIOSAMPLES 27,730 ACTIVE PHYSICIANS IN OUR NETWORK >11,229 GENES COVERED IN TESTING PORTFOLIO WORKING TOGETHER WITH OUR PATIENTS, PHYSICIANS, AND PARTNERS TO DIAGNOSE, UNDERSTAND, AND TREAT RARE, METABOLIC, AND NEURODEGENERATIVE DISEASES. About our company Pharma CENTOGENE REGISTRIES Accelerate and de-risk resource-intensive drug discovery, development, and commercialization processes with unique Real-World Evidence (RWE) on rare and neurodegenerative disease patient cohorts Find out more Diagnostics NOW AVAILABLE: MOX 2.0 WITH TRANSCRIPTOMICS! Revolutionize precision medicine with RNA sequencing for your rare and neurodegenerative disease patients. Explore more Pharma CENTOGENE REGISTRIES Accelerate and de-risk resource-intensive drug discovery, development, and commercialization processes with unique Real-World Evidence (RWE) on rare and neurodegenerative disease patient cohorts Find out more Diagnostics NOW AVAILABLE: MOX 2.0 WITH TRANSCRIPTOMICS! Revolutionize precision medicine with RNA sequencing for your rare and neurodegenerative disease patients. Explore more Diagnose. Understand. Treat. DIAGNOSE. DIAGNOSE. To create a map, we integrate omic data from patients with the same disease to form an atlas representing a comprehensive collection of unique and detailed clinical and biochemical information about each rare disease. Learn more UNDERSTAND. UNDERSTAND. Understanding the details of disease pathways – faulty genes and how they affect associated proteins, and how that leads to specific symptoms – can provide our pharmaceutical partners with valuable clues on how best to research treatments, by developing a drug to target specific molecules along disease pathways for example. Learn more TREAT. TREAT. The combination of omic technologies can identify drugs and drug targets with greater certainty, reducing the risk of failure and making drug development for rare diseases more financially attractive to pharma. Our goal: to enable the cure of 100 diseases in 10 years. Learn more TOP COMPANY NEWS CENTOGENE RECEIVES DELISTING NOTICE FROM NASDAQ Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it received a… 7 Aug, 2024 Read more CENTOGENE PUBLICATION IN BRAIN JOURNAL REVEALS 15% OF PARKINSON’S DISEASE CASES ARE LINKED TO GENETIC FACTORS Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced data… 1 Aug, 2024 Read more C-PATH AND CENTOGENE MOU TO ENHANCE COLLABORATION IN LYSOSOMAL DISEASE RESEARCH AND DRUG DEVELOPMENT TUCSON, Ariz., CAMBRIDGE, Mass., and ROSTOCK, Germany and BERLIN, June 20, 2024 – Critical Path Institute (C-Path), a leader in forming collaborations… 20 Jun, 2024 Read more VISIT OUR ONLINE ORDERING PORTAL CENTOPORTAL® IS A USER-FRIENDLY, ONLINE, WEB-BASED ORDERING PORTAL DESIGNED TO ASSIST YOU AT EVERY STEP OF PROCESSING YOUR PATIENTS' SAMPLES. Order a Test FOOTER For all the latest news in clinical diagnostics and rare disease … Sign up to our newsletter GET IN TOUCH * Careers * Contact Us NEWS & EVENTS * News * Conferences & Events KEY DISEASES * Duchenne Muscular Dystrophy * Gaucher Disease * Niemann-Pick Type C * Parkinson's Disease INVESTORS * Investor Website * News & Events * Stock Information * Governance * General Meeting * Financials * Resources LEGAL * Imprint * Data Protection Policy * HIPAA Privacy * Terms of Use * Terms and Conditions * Cookie Settings * Whistleblower Hotline * Internal Whistleblower System * General Purchasing Terms FOLLOW US Twitter LinkedIn © 2024 CENTOGENE N.V.